Xylem Cuts the Top Line, Holds the Margin, and Quietly Rotates the Whole Portfolio
Organic growth goes to zero and the stock sits 39% off its high — but a $5.5B backlog, a 4-to-3 resegmentation and divestitures argue the problem is pace, not demand
XYL · Earnings Call · 2026-10-27
The guidance cut that wasn't a margin cut
Xylem's third quarter was a test of the company's own operating thesis, and it half-passed. Revenue came in roughly flat organically, orders rose 10%, ending backlog grew 13% to $5.5 billion with book-to-bill above one, and EBITDA margin still expanded 70 basis points to 23.9%. EPS rose 5% to $1.44 — excluding any IEEPA tariff refund benefit. Then the guide moved: full-year reported revenue now down about 1% at $8.95 billion with organic roughly flat, versus the 2%–3% growth promised three months ago.
With that, we're lowering our full year revenue guidance to reflect lower revenue conversion in MCS and WSS... Full year reported revenue is now expected to be down roughly 1% year-over-year at $8.95 billion, with organic revenue roughly flat to last year versus prior guidance of 2%-3% growth.
What did not move is the margin story. Andrea van der Berg, three months into the CFO seat, held roughly 23.2% full-year EBITDA margin — about 100 basis points of expansion — and cut EPS only to $5.40–$5.45, still inside the original framework. On a quarter where revenue was $2.3B and operating margin reached 16.7%, that combination — lost top line, defended bottom line — is the whole story in miniature. The problem is that Xylem has now told investors twice in six months that demand is fine and only the calendar is wrong.
Affordability contagion: from electric to water
The genuinely new information on this call was a transmission mechanism. For several quarters Xylem has flagged softness in electric metering — utilities pushing back on rate increases, curtailing near-term investment. In Q3 that caution crossed over into water metering, historically the more durable half of Measurement & Control Solutions.
“The affordability pressures that have weighed on electric metering are now extending into water metering purchases. Although these purchases are generally funded through utility operating budgets, replacement timing is more discretionary than mission-critical repair and maintenance activity in Water Infrastructure.” — Andrea van der Berg, Chief Financial Officer · 2026-10-27
That is a meaningful escalation, because in July the company was still describing water as the offset — water orders up double digits in both the first and second quarter, funnel up roughly 30%, with an explicit expectation that it would keep going. The affordability pressures keyword is fresh in this quarter's Xylem vocabulary; it was nowhere in the prior-quarter keyword set, which was dominated by walkaway revenue and project delays in electric metering. The concern has moved from one end of the meter business to the other.
Importantly, orders and revenue diverged violently inside MCS: orders up 30% on large water and gas metering awards, book-to-bill 1.16, backlog about $1.3 billion — but revenue down 5%, because those wins deploy in the back half of 2027 and into 2028. The same pattern showed in WSS, where orders grew 6% and drove most of the $200 million sequential backlog build, while revenue fell 2% on slower large capital projects. Management's defense is that the backlog is real and simply dated later. Matthew Pine's framing: the U.S. utility capital exposure is under 10% of revenue, and “the majority of our utility exposure is repair and replace demand, and that cannot be deferred.” — Matthew Pine, Chief Executive Officer · 2026-10-27 True — but the deferrable slice is precisely the slice that just got deferred.
Rotating the portfolio while the tape runs the other way
The bigger strategic event was buried under the guide. Xylem will divest Applied Water International and Specialty Flow Control — its beverage and marine business — and collapse from four segments to three in 2027. Those assets are 9% of revenue but under 5% of EBITDA, and cut China from about 2% of revenue to 1%. They are dilutive, slow-growing, and non-core. Proceeds, notably, do not arrive until "end of 2027, beginning of 2028."
The strategy is honest but repetitive: buy growth, sell drag. The buys — Cornell Pump, Roper Pump, WaterFleet, TriOS — close this year and push leverage from 1.1x toward 1.5x–2x. It also means the enormous buyback is over. The $680M repurchased in Q2 on top of $563M in Q1 turned a near-net-cash balance sheet into $1.65B of effective net debt. Buying that much stock before cutting the top line is the kind of decision only visible in hindsight, and it is why the share count story can't rescue the multiple now.
The offsetting asset is data centers, where orders rose over 200% again in Applied Water and should exit the year at roughly 2% of revenue. Global tape context matters here: AI data center exposure is broadly de-rating over the last 30 days across 48 negative tickers, so Xylem's accelerating order book is running straight into a skeptical market. Pine's longer arc is cleverer than the near-term: “Power is where the most water is used in the AI ecosystem.” — Matthew Pine, Chief Executive Officer · 2026-10-27 That is a 2028–2030 story, and he said so.
Why the stock is not listening
Xylem trades 39% below its October 2025 peak of $152.95 and 26% below its July high, with a 90-day return of −16.9% — a name in a confirmed drawdown reporting into it. The market is pricing a company whose China headwind and 80/20 walkaway are supposedly peaking while growth still refuses to inflect. Management says the same thing every quarter — “Water orders have been up double-digits in both the first and second quarter, and we expect that to continue.” — Matthew Pine, Chief Executive Officer · 2026-07-28 And in July it promised the walkaway drag was at its height: “this will be the height of our walkaway revenue. At close to 2%.” — William Grogan, Chief Financial Officer · 2026-07-28 Both claims were reasonable then; the second is now confirmed (50–100bps of headwind in 2027), the first is not.
What redeems the report is the free-cash-flow and margin discipline that lets a flat-revenue year still produce roughly 100 basis points of margin expansion, with free cash flow margin at 8.1% in Q2 and $444M year-to-date. That is a real operating achievement. But it is the achievement of a company defending itself, not compounding. The Water Solutions complex globally — Kemira, Pentair, Xylem — all now trades on the same question: is water infrastructure spending merely delayed, or is affordability quietly repricing the whole municipal cycle? Xylem's answer is "pace, not demand." Its order book agrees. Its revenue line, three quarters running, does not.